Maryn McKenna, 2015

“Antibiotic resistance means, for all of us, the end of modern medicine as we know it.”

McKenna explained that surgery, cancer treatment, neonatal care, and ordinary infection treatment rely on antimicrobial drugs. She traced how use in medicine and agriculture selects for resistant organisms and spreads risk across borders. The primary record for Maryn McKenna identifies McKenna’s 2015 TED talk on antimicrobial resistance and the medical practices that depend on effective antibiotics. Reading McKenna’s source beside McKenna’s words separates McKenna’s verified context from McKenna’s later paraphrase. September 11 orders McKenna’s series; September 11 does not tie McKenna’s statement to McKenna’s historical anniversary for McKenna. The paired references let McKenna’s readers compare McKenna’s wording with McKenna’s institutional record and McKenna’s biography. That documented trail for McKenna preserves McKenna’s audience, McKenna’s purpose, and McKenna’s necessary limitation. Editors can quote McKenna while keeping McKenna’s original question visible to McKenna’s readers.

Resistance threatens more than the treatment of unusual infections; it weakens the safety net beneath much of modern care. The line translates an evolutionary process into a systems-level warning. A post-antibiotic future is a risk scenario, not a claim that antibiotics have already stopped working everywhere. Patients should not skip prescribed treatment, and stewardship must not become denial of needed drugs. For McKenna, the line becomes McKenna’s interpretive lens rather than McKenna’s complete clinical guidance. Applying McKenna’s idea requires McKenna’s current evidence, McKenna’s affected communities, and McKenna’s suitable outcomes. In health reporting, McKenna should guide McKenna’s inquiry before McKenna supports McKenna’s conclusion. A careful reading of McKenna separates McKenna’s descriptive findings from McKenna’s moral judgment and McKenna’s policy choice. Each layer around McKenna needs McKenna-specific support plus McKenna-specific accountability. That structure keeps McKenna’s memorable words connected to McKenna’s documented scope and limits.

Hospitals, farms, laboratories, regulators, and manufacturers share responsibility for surveillance, prevention, appropriate use, diagnostics, and new products. Infection control and equitable access must advance alongside conservation. McKenna’s warning keeps a slow-moving emergency visible. Its value lies in motivating coordinated stewardship before ordinary infections again become routinely untreatable. The continuing question from McKenna is practical for McKenna: which decision embodies McKenna’s principle? Readers can test McKenna’s relevance when McKenna’s practical questions for McKenna ask who gains, where McKenna’s risk falls, and how McKenna’s improvement gets measured. Organizations honor McKenna by assigning McKenna-specific responsibility, McKenna-specific resources, McKenna-specific timelines, and McKenna-specific public feedback. Individuals may use McKenna for McKenna-specific reflection while qualified care addresses McKenna’s personal relevance. That distinction lets McKenna inspire McKenna-specific action without turning McKenna’s editorial context into McKenna’s medical advice. A transparent McKenna review lets McKenna’s principle face McKenna’s real outcomes and necessary correction.